✦ LIBER ✦

Polyethylene glycol conjugated interleukin-2: Clinical and immunologic effects in patients with advanced renal cell carcinoma

✍ Scribed by Ronald M. Bukowski; James Young; Gary Goodman; Frederick Meyers; Brian F. Issell; James S. Sergi; Denise McLain; Gwen Fyfe; James Finke

Book ID: 104986201
Publisher: Springer US
Year: 1993
Tongue: English
Weight: 487 KB
Volume: 11
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of polyethylene glycol-modified

The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma

✍ James C. Yang; Suzanne L. Topalian; Douglas J. Schwartzentruber; David R. Parkin 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Correlation between clinical response to

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

✍ Bain, C; Merrouche, Y; Puisieux, I; Blay, J-Y; Negrier, S; Bonadona, V; Lasset, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 555 KB

Dexamethasone and interleukin-2 combinat

Dexamethasone and interleukin-2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndrome

✍ TOSHIAKI SHINOJIMA; MOTOTSUGU OYA; HIDAKA KOHNO; KEN MARUMO; MASARU MURAI 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Long-term treatment with low doses of in

Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer

✍ Laura Pavone; Simeone Andrulli; Rosaria Santi; Maria Majori; Carlo Buzio 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Clinical studies on cell-mediated immuni

Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-γ production of lymphocytes

✍ Shinichi Ikemoto; Seiji Wada; Masato Kamizuru; Nobuyuki Hayahara; Taketoshi Kish 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 495 KB

Long-term immunotherapy with low-dose in

Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma

✍ Carlo Buzio; Simeone Andrulli; Rosaria Santi; Laura Pavone; Rodolfo Passalacqua; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views